RESUMEN
Recent laboratory experiments on rodents have increased our understanding of circadian rhythm mechanisms. Typically, circadian biologists attempt to translate their laboratory-based findings to treatment of jet lag symptoms in humans. We aimed to scrutinise the strength of the various links in the translational pathway from animal model to human traveller. First, we argue that the translation of findings from pre-clinical studies to effective jet lag treatments and knowledge regarding longer-term population health is not robust, e.g. the association between circadian disruption and cancer found in animal models does not translate well to cabin crew and pilots, who have a lower risk of most cancers. Jet lag symptoms are heterogeneous, making the true prevalence and the effects of any intervention difficult to quantify precisely. The mechanistic chain between in vitro and in vivo treatment effects has weak links, especially between circadian rhythm disruption in animals and the improvement of jet lag symptoms in humans. While the number of animal studies has increased exponentially between 1990 and 2014, only 1-2 randomised controlled trials on jet lag treatments are published every year. There is one relevant Cochrane review, in which only 2-4 studies on melatonin, without baseline measures, were meta-analysed. Study effect sizes reduced substantially between 1987, when the first paper on melatonin was published, and 2000. We suggest that knowledge derived from a greater number of human randomised controlled trials would provide a firmer platform for circadian biologists to cite jet lag treatment as an important application of their findings.
Asunto(s)
Ritmo Circadiano/fisiología , Síndrome Jet Lag/fisiopatología , Melatonina/metabolismo , Animales , Humanos , Síndrome Jet Lag/metabolismo , Investigación Biomédica TraslacionalRESUMEN
INTRODUCTION: Medical Guidelines for Airline Travel provide information that enables healthcare providers to properly advise patients who plan to travel by air. Not everyone is fit to travel by air and physicians should advise their patients accordingly. They should review the passenger's medical condition, giving special consideration to the dosage and timing of any medications, contagiousness, and the need for special assistance during travel. In general, an individual with an unstable medical condition should not fly; cabin altitude, duration of exposure, and altitude of the destination airport are all considerations when recommending a passenger for flight.
Asunto(s)
Medicina Aeroespacial/métodos , Medicina Aeroespacial/normas , Viaje en Avión , Aeronaves/normas , Examen Físico/métodos , Examen Físico/normas , Aptitud Física , Guías como Asunto , HumanosRESUMEN
The commercial airline industry in the 21st century is a global business, able to transport large numbers of people to almost any part of the world within a few hours. There has long been concern in public health circles about the potential for transmission of communicable diseases, such as TB, on board aircraft. The recent threats from novel and emerging infectious diseases including SARS and pandemic flu has facilitated unprecedented levels of cooperation between international industry representatives, regulators and public health authorities in addressing the issues of air travel and communicable disease. This paper reviews the regulatory environment, ways in which the risks are mitigated through aspects of aircraft design, opportunities for prevention by identifying individuals who may be suffering from a communicable disease prior to flight and the approach used in managing suspected cases of communicable disease on board aircraft.
Asunto(s)
Aeronaves/normas , Aviación/normas , Viaje , Tuberculosis Pulmonar , Enfermedades Transmisibles/transmisión , Brotes de Enfermedades/prevención & control , Salud Global , Humanos , Control de Infecciones/legislación & jurisprudencia , Tuberculosis Pulmonar/prevención & control , Tuberculosis Pulmonar/transmisión , Organización Mundial de la SaludAsunto(s)
Medicina Aeroespacial/normas , Enfermedades Cardiovasculares/complicaciones , Aptitud Física , Viaje , Ambulancias Aéreas , Enfermedades Cardiovasculares/fisiopatología , Enfermedad Crónica , Campos Electromagnéticos , Medicina Basada en la Evidencia/métodos , Humanos , Marcapaso Artificial , Trombosis de la Vena/etiologíaRESUMEN
BACKGROUND: Many employees are required to travel by air as part of their work, and occupational physicians may be asked to give travel health advice and to carry out risk assessments. AIMS: This review examines the stresses of air travel, including those due to travel to and transit through the airport, as well as those arising from the aircraft cabin environment. Guidance is given on the potential effects of these stressors, particularly on those with certain underlying medical conditions, and advice given on how to mitigate some of the effects. Finally, the review looks at in-flight medical incidents and recent developments in in-flight medical care. CONCLUSION: Despite the stresses of air travel, most people are able to fly safely. Some individuals are more vulnerable to these stresses and occupational physicians have an important role in ensuring that an appropriate risk assessment is carried out.